Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ubiquinol in Heart Failure with Preserved Ejection Fraction
NCT02779634Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jul 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of coenzyme q10 in heart failure with preserved ejection fraction (HFpEF), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
coenzyme q10
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02779634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02779634.